Caregivers in LSD microdosing trials for patients with advanced cancer often described the relationship as central. Many reported greater connection, openness, and more meaningful conversations, with some sensing renewed hope and an ability to be more present despite the illness.
They also faced challenges, including uncertainty around an experimental protocol, stigma related to psychedelics, and the emotional burden of serious disease. Practical demands and navigating others’ opinions added stress.
This was a qualitative study of experiences, not a test of clinical effectiveness or safety, so it does not conclude whether LSD microdosing works. It underscores how social context and caregiver support shape how a trial is lived and understood, as described in a recent qualitative study.
In short, caregivers often felt closer yet challenged, and context mattered.